EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1964 Sep 1

PMID 14207774

Citations 36

Authors

E E WERK Jr

J MACGEE

L J SHOLITON

Affiliations

Soon will be listed here.

Citing Articles

Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.

Guengerich F Pharmacol Rev. 2024; 76(6):1104-1132.

PMID: 39054072 PMC: 11549934. DOI: 10.1124/pharmrev.124.001173.

Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for Human Cytochrome P450 Enzyme Induction.

Jacobs M, Kubickova B, Boshoff E Front Toxicol. 2022; 4:880818.

PMID: 35795225 PMC: 9252529. DOI: 10.3389/ftox.2022.880818.

Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study.

Bernasconi C, Pelkonen O, Andersson T, Strickland J, Wilk-Zasadna I, Asturiol D Toxicol In Vitro. 2019; 60:212-228.

PMID: 31158489 PMC: 6718736. DOI: 10.1016/j.tiv.2019.05.019.

The Amelioration of Food: The Milroy Lectures.

Golberg L J R Coll Physicians Lond. 2019; 1(4):385-426.

PMID: 30667659 PMC: 5337612.

The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Richens A Br J Clin Pharmacol. 2012; 1(3):185-7.

PMID: 22454944 PMC: 1402547. DOI: 10.1111/j.1365-2125.1974.tb00233.x.

References

FRANTZ A, KATZ F, JAILER J . 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine. J Clin Endocrinol Metab. 1961; 21:1290-303. DOI: 10.1210/jcem-21-10-1290. View

Butler T . The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. J Pharmacol Exp Ther. 1957; 119(1):1-11. View

ROMANOFF L, Rodriguez R, SEELYE J, Parent C, PINCUS G . The urinary excretion of tetrahydrocortisol, 3 alpha-allotetrahydrocortisol and tetrahydrocortisone in young and elderly men and women. J Clin Endocrinol Metab. 1958; 18(11):1285-95. DOI: 10.1210/jcem-18-11-1285. View

Costa P, GLASER G, BONNY-CASTLE D . Effects of diphenylhydantoin (dilantin) on adrenal cortical function; a study in nonepileptic human subjects. AMA Arch Neurol Psychiatry. 1955; 74(1):88-91. DOI: 10.1001/archneurpsyc.1955.02330130090010. View

SILBER R, Porter C . The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem. 1954; 210(2):923-32. View

MAYNERT E . The metabolic fate of diphenylhydantoin in the dog, rat and man. J Pharmacol Exp Ther. 1960; 130:275-84. View

KATZ F, LIPMAN M, FRANTZ A, JAILER J . The physiologic significance of 6beta-hydroxycortisol in human corticoid metabolism. J Clin Endocrinol Metab. 1962; 22:71-7. DOI: 10.1210/jcem-22-1-71. View

YATES F, Herbst A, Urquhart J . Sex difference in rate of ring A reduction of delta 4-3-keto-steroids in vitro by rat liver. Endocrinology. 1958; 63(6):887-902. DOI: 10.1210/endo-63-6-887. View

Kumagai A, Otomo M, Yano S, Takeuchi N, Nishino K, Ueda H . Inhibition of cortisol metabolism in the liver by other steroids. Endocrinol Jpn. 1959; 6(2):86-92. DOI: 10.1507/endocrj1954.6.86. View

10.

DREKTER I, HEISLER A, SCISM G, Stern S, Pearson S, McGAVACK T . The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids. J Clin Endocrinol Metab. 1952; 12(1):55-65. DOI: 10.1210/jcem-12-1-55. View

11.

Christy N, Hofmann A . Effects of diphenylhydantoin upon adrenal cortical function in man. Neurology. 1959; 9(4):245-8. DOI: 10.1212/wnl.9.4.245. View

12.

LIPMAN M, KATZ F, JAILER J . An alternate pathway for cortisol metabolism. 6 beta-hydroxycortisol production by human tissue slices. J Clin Endocrinol Metab. 1962; 22:268-72. DOI: 10.1210/jcem-22-3-268. View

13.

Robinson W, ENGLE W, Smith D . Effect of diphelhydantoin sodium on liver restitution in the rat following hepatectomy. Proc Soc Exp Biol Med. 1962; 111:477-9. View

14.

Murray F . Outbreak of unexpected reactions among epileptics taking isoniazid. Am Rev Respir Dis. 1962; 86:729-32. DOI: 10.1164/arrd.1962.86.5.729. View

15.

Saltzstein S, ACKERMAN L . Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas. Cancer. 1959; 12(1):164-82. DOI: 10.1002/1097-0142(195901/02)12:1<164::aid-cncr2820120122>3.0.co;2-y. View

16.

Houck J, Jacob R . Connective tissue. VII. Factors inhibiting the dermal chemical response to cortisol. Proc Soc Exp Biol Med. 1963; 113:692-4. DOI: 10.3181/00379727-113-28464. View

17.

BONNYCASTLE D, Bradley A . Diphenylhydantoin and the release of adrenocorticotropic hormone in the albino rat. Endocrinology. 1960; 66:355-63. DOI: 10.1210/endo-66-3-355. View

18.

OPPENHEIMER J, TAVERNETTI R . Studies on the thyroxine-diphenylhydantoin interaction: effect of 5,5'-diphenylhydantoin on the displacement of L-thyroxine from thyroxine-binding globulin (TBG). Endocrinology. 1962; 71:496-504. DOI: 10.1210/endo-71-3-496. View

19.

STEMPFEL Jr R, SIDBURY Jr J, Migeon C . beta-Glucuronidase hydrolysis of urinary corticosteroid conjugates: the effect of salicylate glucuronoside as a competing substrate and the effect of enzyme inactivation. J Clin Endocrinol Metab. 1960; 20:814-24. DOI: 10.1210/jcem-20-6-814. View

20.

Rosenfeld S, SWILLER A, SHENOY Y, MORRISON A . Syndrome simulatingqymphosarcoma induced by diphenylhydantoin sodium. JAMA. 1961; 176:491-3. DOI: 10.1001/jama.1961.03040190013004. View